Three new studies in diabetes include vitamin D deficiency; eliminating racial disparities in diabetes care; and the link between emotions and insulin resistance.
Edward C. Chao, DO, offers three new strategies that both patients and physicians can take to prevent diabetes.
When your patient is also your neighbor it can get, well, awkward. That's why Melissa Young, MD, has shared her tips on how to handle seeing patients outside of the office.
Updates in Obesity from the American Association of Clinical Endocrinologists Annual Scientific & Clinical Congress
How can less exercise yield better blood sugar and decrease risk of heart disease in diabetes patients? A new study has answers.
Follow-on biologics could reduce insulin therapy costs for diabetes patients, but how? This new study reveals.
Edward C. Chao, DO, says collaboration is the answer and offers three simple steps.
New study finds higher percentage of body fat is associated more with abnormal blood glucose in normal and overweight nondiabetic subjects.
The new diabetes tech in question is the expanding pool of continuous glucose monitoring systems. So, what's your CGM IQ?
New research also found that continuous glucose monitoring by type 1 diabetes patients improved overall glucose control and enhanced quality of life.
New diabetes studies find SGLT2i may reduce all-cause mortality; that telemedicine can improve T2DM care; and that broader screening criteria are better.
Primary hyperparathyroidism--asymptomatic but curable. Here are three clinical pearls to help guide diagnosis and management.
The GLP-1 receptor agonist/metformin combination did not support weight loss in this population but did increase pregnancy rates per in vitro embryo transfer.
Empagliflozin shown to significantly reduce liver fat in patients with T2DM, according to a new study.
In a new study, the GLP-1 receptor agonist semaglutide was associated with greater weight loss than placebo -- and liraglutide.